Alpha-adrenergic blocking agent in childhood pheochromocytoma
Gupta, S.; Ternberg, J.L.; Weldon, V.V.; Pagliara, A.S.
Surgery 74(4): 545-550
1973
ISSN/ISBN: 0039-6060 PMID: 4729218 Document Number: 57396
Document emailed within 1 workday
Related Documents
Miki, H. 1983: Effect of befunolol ophthalmic solution, alpha, beta-adrenergic blocking agent, on secondary glaucoma Nippon Ganka Gakkai Zasshi 87(1): 1-13Calvagno, M. 1982: Usefulness of an alpha-adrenergic blocking agent (nicergoline) in the treatment of diabetic angiopathy of lower limbs Il Farmaco; Edizione Pratica 37(6): 200-205
Kitamura, S. 1980: The treatment of asthmatic patients using an alpha-adrenergic receptor blocking agent, co-dergocrine mesylate ('Hydergine') Pharmatherapeutica 2(5): 330-336
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Musial, W.; Tracz, W.; Krzemińska-Pakula, M. 1971: New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease Polski Tygodnik Lekarski 26(22): 834-836
Dufour, R.; Scazziga, B.; Schelling, J.L. 1970: Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 145-147
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Baïsset, A.; Dang-Tran, L.; Montastruc, P. 1971: Effect of an adrenergic beta-blocking agent on adrenaline-induced hyperglycemia in hypophysectomized dogs Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(11): 2209-2214
Limon, L. 1990: The use of alpha 1 adrenergic blocking agents for hypertension American Pharmacy 30(6): 54-58
Renouard, A.; Widdowson, P.S.; Millan, M.J. 1994: Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes Journal of Pharmacology and Experimental Therapeutics 270(3): 946-957
Hara, Y.; Sato, E.; Miyagishi, A.; Aono, S.; Nakatani, H. 1979: Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 75(7): 707-720
Perrigot, M.; Vannier, A.; Bor, Y. 1986: Alpha adrenergic blocking agents in disorders of the bladder sphincter La Revue du Praticien 36(5): 223-228
Balsamo, A.; Macchia, B.; Macchia, F.; Martinelli, A.; Tognetti, P.; Veracini, C.A. 1981: Conformational properties of benzodioxan derivatives with alpha-adrenergic blocking activity Molecular Pharmacology 20(2): 371-376
Metelitsa, V.I.; Filatova, N.P. 1990: Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study) Kardiologiia 30(5): 8-14
Huidobro-Toro, J.P.; Carpi, A. 1976: Selective blocking properties of chloro acetyl catechol (CAC) on the alpha-adrenergic receptor Archives Internationales de Pharmacodynamie et de Therapie 222(2): 180-192
Khouili, M.; Guillaumet, G.; Coudert, G.; Pujol, M.D. 1996: Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II) Farmaco 51(3): 185-188
Zebrowska-Lupina, I. 1978: Studies on the mechanisms of central action of alpha-adrenergic receptor blocking agents Polish Journal of Pharmacology and Pharmacy 30(4): 455-458
Apponi-Battini, G.; Barra, A.; De Simone, C.; Rossi, F.; Berrino, L.; Cazzola, M.; Marmo, E. 1984: Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents Journal of Medicine 15(2): 126-134
Mirouze, J.; Jullien, C.; Monnier, L.; Olivier, C. 1974: Effects of diazoxide, clonidine and a new alpha-blocking agent on renal clearances Clinical Nephrology 2(5): 191-196